Quality of Life and Body Mass Index in Overweight Adult Women with Polycystic Ovary Syndrome During a Lifestyle Modification Program.

OBJECTIVE To evaluate changes in body mass index (BMI) and health-related quality of life (HRQoL), including an acne parameter, of overweight adult women with polycystic ovary syndrome (PCOS) during a lifestyle modification program. DESIGN Prospective longitudinal within-patient study. SETTING Department of Reproductive Medicine of the Ghent University Hospital (Belgium). PARTICIPANTS Thirty-three overweight (BMI ≥ 25 kg/m²) women with PCOS between age 18 and 43 years. METHODS Participants followed a 24-week lifestyle modification program consisting of a diet, exercise, and psychological subprogram. BMI was assessed at Weeks 0, 8, 16, and 24 of the program. The HRQoL was measured at Week 0, 12, and 24 of the program using the PolyCystic Ovary Syndrome Questionnaire (PCOSQ) and a Visual Analogue Scale (VAS) to evaluate the influence of acne on HRQoL. RESULTS During a 24-week period no significant decrease in BMI occurred (mean difference = 1.71, 95% confidence interval [CI] [-1.38, 4.81]. During that period, there was a significant positive evolution of the total PCOSQ score, F(2, 37.5) = 23.7, the emotions, F(2, 37.9) = 4.2, weight, F(2, 42.1) = 24.8, body hair, F(2, 35.6) = 3.3, and infertility problems domain scores, F(2, 43.1) = 15.64, of the PCOSQ, as well as of the acne VAS score, F(2, 29.3) = 4.2. These effects primarily occurred during the first 12 weeks. CONCLUSION In spite of no significant changes in BMI, the HRQoL of overweight adult women with PCOS significantly improved during a 24-week lifestyle modification program.

[1]  J. Kenardy,et al.  Psychological interventions for overweight or obesity. , 2014, The Cochrane database of systematic reviews.

[2]  M. Weinblatt,et al.  Factors Associated With Attrition in a Longitudinal Rheumatoid Arthritis Registry , 2013, Arthritis care & research.

[3]  Shinichi Nakagawa,et al.  A general and simple method for obtaining R2 from generalized linear mixed‐effects models , 2013 .

[4]  B. Falissard,et al.  Sample size requirements for the internal validation of psychiatric scales , 2011, International journal of methods in psychiatric research.

[5]  L. Moran,et al.  Lifestyle changes in women with polycystic ovary syndrome. , 2011, The Cochrane database of systematic reviews.

[6]  P. Lally,et al.  How are habits formed: Modelling habit formation in the real world , 2010 .

[7]  G. Brinkworth,et al.  Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. , 2010, Fertility and sterility.

[8]  C. Castelo-Branco,et al.  Comprehensive clinical management of hirsutism , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  D. Guzick,et al.  Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin. , 2010, Fertility and sterility.

[10]  J. Vrbíková,et al.  Obesity and Polycystic Ovary Syndrome , 2009, Obesity Facts.

[11]  G. Brinkworth,et al.  The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[12]  D. Goulis,et al.  Consensus on infertility treatment related to polycystic ovary syndrome , 2008 .

[13]  L. Liao,et al.  Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: A pilot investigation , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[14]  M. Noakes,et al.  Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome—A pilot study , 2007, Appetite.

[15]  J. Hall,et al.  Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. , 2007, Human reproduction update.

[16]  Chris Rissel,et al.  Promoting walking with pedometers in the community: the step-by-step trial. , 2007, American journal of preventive medicine.

[17]  Brady T. West,et al.  Linear Mixed Models: A Practical Guide Using Statistical Software , 2006 .

[18]  M. Eijkemans,et al.  PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO‐II anovulation and association with metabolic factors , 2006, BJOG : an international journal of obstetrics and gynaecology.

[19]  K. Hoeger,et al.  Role of lifestyle modification in the management of polycystic ovary syndrome. , 2006, Best practice & research. Clinical endocrinology & metabolism.

[20]  R. Kimmig,et al.  Determinants of emotional distress in women with polycystic ovary syndrome , 2006 .

[21]  J. Glanville,et al.  Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. , 2006, Human reproduction.

[22]  H. Mason,et al.  Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36) , 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[23]  G. Guyatt,et al.  Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. , 2004, Journal of clinical epidemiology.

[24]  D. Guzick,et al.  A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. , 2004, Fertility and sterility.

[25]  K. Benes,et al.  The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation. , 2004, Human reproduction.

[26]  Scott E Crouter,et al.  Validity of 10 electronic pedometers for measuring steps, distance, and energy cost. , 2003, Medicine and science in sports and exercise.

[27]  J. Fox.  Effect Displays in R for Generalised Linear Models , 2003 .

[28]  L. Moran,et al.  The role of lifestyle modification in polycystic ovary syndrome , 2002, Trends in Endocrinology & Metabolism.

[29]  U. Pagotto,et al.  Obesity and the polycystic ovary syndrome , 2002, International Journal of Obesity.

[30]  G. Molenberghs,et al.  Linear Mixed Models for Longitudinal Data , 2001 .

[31]  R. Norman,et al.  Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. , 1999, The Journal of clinical endocrinology and metabolism.

[32]  G. Guyatt,et al.  Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). , 1998, The Journal of clinical endocrinology and metabolism.

[33]  D. Ferriman,et al.  Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.

[34]  R. Azziz,et al.  Visually scoring hirsutism. , 2010, Human reproduction update.

[35]  N. Reame,et al.  Health-related quality of life issues in women with polycystic ovary syndrome. , 2005, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[36]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[37]  E. Muls,et al.  Consensus 2002 over obesitas van de "Belgian Association for the Study of Obesity (BASO)" , 2003 .

[38]  N. Nakamura,et al.  Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. , 2001, Human reproduction.

[39]  D. Polit-O'hara,et al.  Nursing Research: Principles and Methods , 1978 .